ENGN
#3872
enGene Therapeutics Inc. - Common Stock
1.9 0 USD
+0.02%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+2.15%
Monthly Change
+9.20%
6 month change
-79.14%
Year Change
-77.38%
Previous Close
1.8 6
Open
1.9 0
Low
1.9 0
High
1.9 0
Volume
9
Financials
- Market Capitalization 127.28 M
- Employee 82
- Founded N/A
- CEO N/A
- Website www.engene.com
- Headquarter Canada (Federal Level)
- FIGI BBG01J1GCYW7
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
3.12
Price to sales ratio
-967.67
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3867 |  GNLX Genelux Corporation - Common Stock | 2.89 USD | -2.36% | -2.69% | -3.67% | -6.17% | 129.59 M USD | ||
| 3870 |  SPRB Spruce Biosciences, Inc. - Common Stock | 46.36 USD | -4.18% | -8.54% | -8.96% | +321.45% | 127.60 M USD | ||
| 3874 |  GUTS Fractyl Health, Inc. - Common Stock | 0.80 USD | +5.26% | 0.00% | -6.98% | -46.67% | 126.92 M USD | ||
| 3876 |  CUE Cue Biopharma, Inc. - Common Stock | 31.28 USD | +1.16% | -3.28% | +21.10% | +4368.57% | 126.55 M USD |
Frequently asked questions about enGene Therapeutics Inc. - Common Stock
What is the enGene Therapeutics Inc. - Common Stock stock price today?
The current price of enGene Therapeutics Inc. - Common Stock (ENGN) is 1.9. Over the past 24 hours, the stock has changed by +2.15%. Follow the ENGN chart for real-time price dynamics.
What is the stock ticker of enGene Therapeutics Inc. - Common Stock?
enGene Therapeutics Inc. - Common Stock trades under the ticker ENGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is enGene Therapeutics Inc. - Common Stock stock going up?
ENGN has changed by +1.60% over the last week, +9.20% over the last month, and -77.38% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does enGene Therapeutics Inc. - Common Stock release financial reports?
Yes. You can track enGene Therapeutics Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was enGene Therapeutics Inc. - Common Stock net income for the last quarter?
enGene Therapeutics Inc. - Common Stock reported net income of -30.23 M for the last quarter. The previous quarter showed -29.75 M, which means net income changed by -1.60%.
How many employees does enGene Therapeutics Inc. - Common Stock have?
As of the latest available data, enGene Therapeutics Inc. - Common Stock has 82 employees. Workforce size can provide additional context about the company's scale and operations.
What is enGene Therapeutics Inc. - Common Stock EBITDA?
enGene Therapeutics Inc. - Common Stock EBITDA is -31.74 M, and its EBITDA margin is -109.44 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy enGene Therapeutics Inc. - Common Stock stock?
You can buy enGene Therapeutics Inc. - Common Stock (ENGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in enGene Therapeutics Inc. - Common Stock stock?
Investing in enGene Therapeutics Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENGN chart and related analysis on metatrader.com as part of your research.